Bausch + Lomb Corporation Common Shares (NY:BLCO)

17.11 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bausch + Lomb Corporation Common Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Bausch + Lomb Announces Second-Quarter 2023 Results and Raises Full-Year 2023 Revenue Outlook

August 02, 2023

From Bausch + Lomb Corporation

Via Business Wire

Earnings Preview: Bausch & Lomb ↗

August 01, 2023

Via Benzinga

Bausch + Lomb Solidifies Leadership Team

August 01, 2023

From Bausch + Lomb Corporation

Via Business Wire

Analyst Ratings for Bausch & Lomb ↗

July 24, 2023

Via Benzinga

Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2

July 11, 2023

From Bausch + Lomb Corporation

Via Business Wire

Analyst Ratings for Bausch & Lomb ↗

July 03, 2023

Via Benzinga

9 Analysts Have This to Say About Bausch & Lomb ↗

May 19, 2023

Via Benzinga

Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink ↗

July 06, 2023

Bausch + Lomb Corporation (NYSE: BLCO) has acquired Johnson & Johnson's (NYSE: JNJ) eye and contact lens drops brand Blink for $106.5 million to bolster its position in over-the-counter (OTC)...

Via Benzinga

Bausch + Lomb Expands OTC Product Line with Acquisition of Blink® Eye Drops

July 06, 2023

From Bausch + Lomb Corporation

Via Business Wire

Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday ↗

June 30, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Amazon Hires Dozens of Former FTC Officials, Volkswagen Discusses With Tesla to Adopt North American Charging Standard, FDA Approves First Hemophilia A BioMarin Gene Therapy: Today's Top Stories ↗

June 30, 2023

New York Post

Via Benzinga

Looking Into Bausch & Lomb's Return On Capital Employed ↗

May 12, 2023

Via Benzinga

Bausch & Lomb's Return On Capital Employed Insights ↗

May 09, 2023

Via Benzinga

Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis ↗

June 30, 2023

Bausch + Lomb Corporation (NYSE: BLCO) has agreed to acquire 'front of eye' ophthalmology assets for $1.75 billion in upfront cash, plus additional milestone payments from Novartis AG (NYSE:

Via Benzinga

Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)

June 30, 2023

Via ACCESSWIRE

Bausch + Lomb Will Acquire XIIDRA®

June 30, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches PreserVision® AREDS 2 Formula Soft Gels Plus CoQ10 in the United States

June 12, 2023

From Bausch + Lomb Corporation

Via Business Wire

Inflationary Factors And Slow Product Uptake Could Be Headwinds For Bausch + Lomb, Analyst Says ↗

May 08, 2023

Via Benzinga

Recap: Bausch & Lomb Q1 Earnings ↗

May 03, 2023

Via Benzinga

Bausch + Lomb Announces New Scientific Data and Analyses Featuring Consumer, Vision Care and Pharmaceutical Products Will Be Presented During American Optometric Association's Optometry's Meeting

June 08, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches Biotrue® Hydration Boost Contact Lens Rehydrating Drops in the United States

June 06, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches Bausch + Lomb INFUSE® Multifocal Silicone Hydrogel Contact Lenses in the United States

June 05, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Key Leadership Changes

June 01, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye Disease

May 18, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces First-Quarter 2023 Results and Provides 2023 Guidance

May 03, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Releases Annual Environmental, Social and Governance Report

May 01, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting

April 26, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results

April 25, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System

April 24, 2023

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces the Presentation of New Data on Products and Pipeline Programs at the Association for Research in Vision and Ophthalmology Meeting

April 20, 2023

From Bausch + Lomb Corporation

Via Business Wire

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.